Adoptive transfer of NDN (isolated from LLC-GCSF tumor-bearing mice) clearly showed that NDN possess anti-cancer ability in vivo, whereas LDN had no clinical effect on tumor growth, demonstrating the differential potential of these two subpopulations (Figure 4). The gene discussed is NDN; the disease is cancer.